Table 1. Surgical Treatment of Dermatophytosis Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Surgical Treatment of Dermatophytosis Market Restraints

Table 3. Surgical Treatment of Dermatophytosis Market Trends

Table 4. Surgical Treatment of Dermatophytosis Industry Policy

Table 5. Global Surgical Treatment of Dermatophytosis Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Surgical Treatment of Dermatophytosis Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Surgical Treatment of Dermatophytosis Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Surgical Treatment of Dermatophytosis Mergers & Acquisitions, Expansion Plans

Table 9. Global Surgical Treatment of Dermatophytosis Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Surgical Treatment of Dermatophytosis Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Surgical Treatment of Dermatophytosis Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Surgical Treatment of Dermatophytosis Upstream (Raw Materials)

Table 14. Global Surgical Treatment of Dermatophytosis Typical Customers

Table 15. Surgical Treatment of Dermatophytosis Typical Distributors

Table 16. By Type, Global Surgical Treatment of Dermatophytosis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Surgical Treatment of Dermatophytosis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Surgical Treatment of Dermatophytosis Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Surgical Treatment of Dermatophytosis Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2018-2029

Table 23. Bausch Health Company Information, Head Office, Market Area and Industry Position

Table 24. Bausch Health Company Profile and Main Business

Table 25. Bausch Health Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 26. Bausch Health Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Bausch Health Recent Developments

Table 28. Galderma S.A. Company Information, Head Office, Market Area and Industry Position

Table 29. Galderma S.A. Company Profile and Main Business

Table 30. Galderma S.A. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 31. Galderma S.A. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. Galderma S.A. Recent Developments

Table 33. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 34. Novartis AG Company Profile and Main Business

Table 35. Novartis AG Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 36. Novartis AG Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. Novartis AG Recent Developments

Table 38. Pfizer, Inc. Company Information, Head Office, Market Area and Industry Position

Table 39. Pfizer, Inc. Company Profile and Main Business

Table 40. Pfizer, Inc. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 41. Pfizer, Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. Pfizer, Inc. Recent Developments

Table 43. Moberg Pharma AB Company Information, Head Office, Market Area and Industry Position

Table 44. Moberg Pharma AB Company Profile and Main Business

Table 45. Moberg Pharma AB Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 46. Moberg Pharma AB Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 47. Moberg Pharma AB Recent Developments

Table 48. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 49. Bayer AG Company Profile and Main Business

Table 50. Bayer AG Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 51. Bayer AG Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 52. Bayer AG Recent Developments

Table 53. Dr. Reddy’s Laboratories Ltd. Company Information, Head Office, Market Area and Industry Position

Table 54. Dr. Reddy’s Laboratories Ltd. Company Profile and Main Business

Table 55. Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 56. Dr. Reddy’s Laboratories Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 57. Dr. Reddy’s Laboratories Ltd. Recent Developments

Table 58. Cipla Ltd. Company Information, Head Office, Market Area and Industry Position

Table 59. Cipla Ltd. Company Profile and Main Business

Table 60. Cipla Ltd. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 61. Cipla Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 62. Cipla Ltd. Recent Developments

Table 63. Medimetriks Pharmaceuticals, Inc. Company Information, Head Office, Market Area and Industry Position

Table 64. Medimetriks Pharmaceuticals, Inc. Company Profile and Main Business

Table 65. Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 66. Medimetriks Pharmaceuticals, Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 67. Medimetriks Pharmaceuticals, Inc. Recent Developments

Table 68. Sanofi S.A. Company Information, Head Office, Market Area and Industry Position

Table 69. Sanofi S.A. Company Profile and Main Business

Table 70. Sanofi S.A. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 71. Sanofi S.A. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 72. Sanofi S.A. Recent Developments

Table 73. GlaxoSmithKline Plc. Company Information, Head Office, Market Area and Industry Position

Table 74. GlaxoSmithKline Plc. Company Profile and Main Business

Table 75. GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 76. GlaxoSmithKline Plc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 77. GlaxoSmithKline Plc. Recent Developments

Table 78. Teva Pharmaceutical industries Ltd. Company Information, Head Office, Market Area and Industry Position

Table 79. Teva Pharmaceutical industries Ltd. Company Profile and Main Business

Table 80. Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 81. Teva Pharmaceutical industries Ltd. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 82. Teva Pharmaceutical industries Ltd. Recent Developments

Table 83. Cardinal Health Inc. Company Information, Head Office, Market Area and Industry Position

Table 84. Cardinal Health Inc. Company Profile and Main Business

Table 85. Cardinal Health Inc. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 86. Cardinal Health Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 87. Cardinal Health Inc. Recent Developments

Table 88. Viatris Inc. Company Information, Head Office, Market Area and Industry Position

Table 89. Viatris Inc. Company Profile and Main Business

Table 90. Viatris Inc. Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 91. Viatris Inc. Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 92. Viatris Inc. Recent Developments

Table 93. Almirall, S.A Company Information, Head Office, Market Area and Industry Position

Table 94. Almirall, S.A Company Profile and Main Business

Table 95. Almirall, S.A Surgical Treatment of Dermatophytosis Models, Specifications, and Application

Table 96. Almirall, S.A Surgical Treatment of Dermatophytosis Revenue and Gross Margin, US$ Million, 2018-2023

Table 97. Almirall, S.A Recent Developments

List of Figures

Figure 1. Surgical Treatment of Dermatophytosis Picture

Figure 2. Global Surgical Treatment of Dermatophytosis Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Surgical Treatment of Dermatophytosis Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Surgical Treatment of Dermatophytosis Market Share of Global, 2018-2029

Figure 5. Global Surgical Treatment of Dermatophytosis Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Surgical Treatment of Dermatophytosis Key Participants, Market Share, 2022

Figure 7. Surgical Treatment of Dermatophytosis Industry Chain

Figure 8. Surgical Treatment of Dermatophytosis Procurement Model

Figure 9. Surgical Treatment of Dermatophytosis Sales Model

Figure 10. Surgical Treatment of Dermatophytosis Sales Channels, Direct Sales, and Distribution

Figure 11. Dermatophytic Onychomycosis Therapeutic Lasers

Figure 12. Photodynamic Therapy

Figure 13. By Type, Global Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 14. By Type, Global Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2018-2029

Figure 15. Hospital

Figure 16. Clinic

Figure 17. Others

Figure 18. By Application, Global Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 19. By Application, Global Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2018-2029

Figure 20. By Region, Global Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2018-2029

Figure 21. North America Surgical Treatment of Dermatophytosis Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022

Figure 23. Europe Surgical Treatment of Dermatophytosis Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022

Figure 25. Asia Pacific Surgical Treatment of Dermatophytosis Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022

Figure 27. South America Surgical Treatment of Dermatophytosis Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022

Figure 29. Middle East & Africa Surgical Treatment of Dermatophytosis Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 31. By Type, U.S. Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 33. Europe Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 34. By Type, Europe Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 35. By Application, Europe Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 36. China Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 37. By Type, China Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 38. By Application, China Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 39. Japan Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 40. By Type, Japan Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 41. By Application, Japan Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 42. South Korea Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 43. By Type, South Korea Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 44. By Application, South Korea Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 45. Southeast Asia Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 46. By Type, Southeast Asia Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 47. By Application, Southeast Asia Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 48. India Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 49. By Type, India Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 50. By Application, India Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 51. Middle East & Africa Surgical Treatment of Dermatophytosis Consumption Value, 2018-2029, US$ Million

Figure 52. By Type, Middle East & Africa Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 53. By Application, Middle East & Africa Surgical Treatment of Dermatophytosis Consumption Value Market Share, 2022 VS 2029

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up and Top-down Approaches

Figure 57. Top-down Approaches